Thus, CPX down-regulated TOP2A expression and TOP2A knockdown further enhanced CPX anti-tumor effects, suggesting that at least part of the CPX effects on LUAD were mediated by TOP2A. The gene discussed is TOP2A; the disease is neoplasm.